Skip to main content

Table 1 Patient and tumour characteristics in 33 patients treated with cetuximab based chemoradiotherapy

From: Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy

  Patients (n) %
Patients included 33 100
Median age (range) 61 (33 - 76)
Gender   
Male 23 70
Female 10 30
Performance Status (ECOG*)   
0 23 70
1 9 27
2 1 3
Tumour marker   
CEA, median (range) 2,4 μg/l (0.5 - 50,3)
CA 19-9, median (range) 10 kU/l (1 - 298)
Clinical T-staging (TRUS §§ )   
cT2 6 18
cT3 24 73
cT4 3 9
Clinical N-staging (TRUS §§ )   
cN negative 10 30,3
cN positive 23 69,7
TRG § (JSCCR ┼┼ )   
0 1 3
1a 6 18
1b 4 12
2 19 58
3 3 9
  1. §§: Transrectal ultrasound; §: Tumour regression grade; ┼┼ = Japanese Society for Cancer of the Colon and Rectum